PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Analysts In Media, Inc. (AIM, Inc.)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Analysts in Media Announces Release of Q3 Edition of Future Pharmaceuticals - Analysts In Media released the Q3 August 2006 edition of Future Pharmaceuticals a high-level publication both online and in print, designed to provide senior-level business and technology executives with an in-depth analysis
Analysts in Media Announces Release of Q3 Edition of Future Pharmaceuticals

 

NewswireToday - /newswire/ - New York City, NY, United States, 2006/08/23 - Analysts In Media released the Q3 August 2006 edition of Future Pharmaceuticals a high-level publication both online and in print, designed to provide senior-level business and technology executives with an in-depth analysis.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Analysts In Media, Inc. (AIM) released the Q3 August 2006 edition of Future Pharmaceuticals (FP) a high-level publication both online and in print, designed to provide senior-level business and technology executives with an in-depth analysis of, and key insight into market trends and innovative technologies within the Pharmaceutical and Biotechnology industry.

This Q3 edition of FP features keynote editorial thought leadership from the most respected industry analysts, experts, and solution providers within the Pharmaceutical and Biotechnology world. The leading topics of discussion in this edition include Drug Discovery, Clinical Trails, Sales and Marketing, Learning and Training, and Conferences and Meetings.

Featured editorial contributors include:

• Nancy Grey, Director of Pharmacovigilance Education and Process Documentation in the Safety and Risk Management Organization, Pfizer.
• Janice Arnold, Associate Director of Marketing and Sales Information Analysis, Daiichi Sankyo
• Rebecca Kush, President, Clinical Data Interchange Standards Consortium (CDISC)
• Daniel C. Sullivan, Associate Director, National Cancer Institute

Drug Discovery:
Dr. Daniel C. Sullivan, Associate Director, National Cancer Institute, Fred Vinick, Senior VP of Drug Discovery. Genzyme Corporation, and Samuel Aronson, Director of IT, Harvard Medical Center

Clinical Trials:
Rebecca Kush, President, CDISC, Kenneth Getz, Senior Research Fellow, Tufts Center for the Study of Drug Development, and Roni Thaler, President and CEO, CISCRP

Sales and Marketing: Janice Arnold, Associate Director of Marketing and Sales Information Analysis, Daiichi Sankyo

Learning and Training:
Nancy Grey, Director of Pharmacovigilance Education Documentation in the Safety and Risk Management Organization, Pfizer, Stephen McGuffin, Assistant VP Sales Training and Management Development, Wyeth, and Don Kraft Associate Director of Human Resources (Learning and Organizational Development Department), Genentech

“We are delighted that these thought leaders have been kind enough to lend their expertise to this edition of the Future Pharmaceuticals,” says Amir Nikaein, CEO. “This further cements our ambition to make FP the leading information resource for buyers of technology and services within the Pharmaceutical and Biotechnology industry.”

The publication is available in both print and online.

About Future Pharmaceuticals

Published by Analysts in Media, Inc., Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharmaceutical companies as well as small, specialty, and biotech, Future Pharmaceuticals is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide.

About Analysts In Media

Analysts In Media, Inc. is a leading global provider of specialized information services for the professional and enthusiast markets, actively bringing buyers and sellers together across targeted media channels – publications, events and online.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Analysts In Media, Inc. (AIM, Inc.)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Analysts in Media Announces Release of Q3 Edition of Future Pharmaceuticals

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Alaina Cagliostro - AnalystsinMedia.com 
646-747-0560 acagliostro[.]analystsinmedia.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Analysts In Media, Inc. (AIM, Inc.) securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Analysts In Media, Inc. (AIM, Inc.) / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Al Rowaad Advocates & Legal Consultants





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)